Health Policy Resolutions from the AMA House of Delegates 2016 Interim Meeting

The HOD further discussed prioritizing billing changes for high-deductible patients, limiting the burden of Maintenance of Certification requirements and the physician workforce crisis.

An ACR Ally
Dr. Bryant calls the AMA an ally of the ACR, providing the strength and breadth to help the rheumatology community meet its shared goals, particularly in 2017.

“It will likely be a fast-moving time once the new Congress is seated after the inauguration,” Dr. Bryant says.

Dr. Bryant asks all rheumatologists to join the AMA or renew their AMA memberships—and to “vote” for the ACR and rheumatology as their specialty designation—so that rheumatology can maintain and increase its voice in AMA policy-making bodies and activity.

Read more AMA news coverage from the 2016 Interim Meeting.

Kelly April Tyrrell writes about health, science and health policy. She lives in Madison, Wis.

Reference
1. American Medical Association. AMA Vision on Health Reform. 2016 Nov 15. http://www.the-rheumatologist.org/wp-content/uploads/2016/11/ama-vision-on-health-reform.pdf.

As 2017 unfolds—a year when MACRA begins, lawmakers take steps to dismantle the health reform efforts of the past eight years, and political uncertainty is the rule—it is imperative that the ACR leverage its advocacy agenda by maintaining its seat at the American Medical Association’s (AMA’s) House of Delegates (HOD), says Gary Bryant, MD, FACP…

There is a saying that if the American Medical Association (AMA) did not exist, we would have to invent it. That is just what Dr. Nathan S. Davis did back in 1845 when he called for a national medical convention and laid the foundation for the establishment of the AMA in 1847. This new group would…

Two ACR-led resolutions on in-office specialty drug dispensing and the proposed NIH Public Access Plan passed the House of Delegates and will become AMA policy.

At the virtual interim meeting Nov. 13–17, the ACR delegation led a successful bid to update American Medical Association policies on home infusion and copay accumulators and supported efforts against the Most Favored Nation drug pricing model.

Why Keep a Seat at the AMA Table?

The ACR’s Representation in American Medical Association Critical as Review Looms

Rheumatology Priorities Advanced at Busy AMA House of Delegates Meeting

Successful Resolutions, Policy Updates at AMA House of Delegates 2020 Interim Meeting

Related Articles